screening
No description yet: the sentence for this tag has not been written. 11 records carry it: 11 people.
Related tags
11 records
| Cancers | Other tags | ||||
|---|---|---|---|---|---|
Constance D. Lehman Professor of Radiology, Harvard Medical School; Co-Director, Breast Imaging Research Center, Massachusetts General Hospital · Massachusetts General Hospital Cancer Center Breast radiologist who co-developed the Mirai AI model that predicts breast cancer risk from a mammogram. | HR-positive / HER2-negative breast cancer | none | ai, breast | ||
Denise R. Aberle Professor of Radiology and Bioengineering, UCLA · UCLA Jonsson Comprehensive Cancer Center Principal investigator of the National Lung Screening Trial, which first proved CT screening saves lives. | Non-small-cell lung cancer | none | lung, radiology | ||
Harry J. de Koning Professor of Public Health and Screening Evaluation, Erasmus MC · Erasmus MC Cancer Institute Led the NELSON trial, which confirmed CT screening cuts lung cancer deaths in Europe and shaped screening policy. | Non-small-cell lung cancer, Prostate cancer | none | lung, epidemiology | ||
Kristina Lång Associate Professor of Diagnostic Radiology, Lund University; Breast Radiologist, Skåne University Hospital · Skåne University Hospital / Lund University Cancer Centre Led MASAI, the first randomised trial of AI-supported mammography screening, which found more cancers with half the radiologist workload. | HR-positive / HER2-negative breast cancer | none | ai, breast, sweden | ||
Mark Schiffman Senior Investigator, Division of Cancer Epidemiology and Genetics, National Cancer Institute · National Cancer Institute (NIH) NCI epidemiologist whose HPV natural history studies underpin HPV-based cervical screening and risk-based management worldwide. | Cervical cancer | none | hpv, epidemiology | ||
Michael Bretthauer Professor of Medicine, University of Oslo; Gastroenterologist, Oslo University Hospital · Oslo University Hospital, The Norwegian Radium Hospital Led NordICC, the first randomised trial of screening colonoscopy, which found smaller benefits than many expected. | Colorectal cancer | none | colorectal, epidemiology | ||
Peter Sasieni Professor of Cancer Epidemiology, Queen Mary University of London; Director, Cancer Prevention Trials Unit · Barts Cancer Institute / Barts Health NHS Trust Epidemiologist who showed HPV vaccination has nearly eliminated cervical cancer in vaccinated English women and leads NHS-Galleri. | Cervical cancer | none | hpv, prevention | ||
Regina Barzilay School of Engineering Distinguished Professor for AI and Health, MIT; AI Faculty Lead, Jameel Clinic · David H. Koch Institute for Integrative Cancer Research at MIT Computer scientist who built Mirai and Sybil, AI models that predict breast and lung cancer risk years before diagnosis. | HR-positive / HER2-negative breast cancer, Non-small-cell lung cancer | none | ai, risk-prediction | ||
Sigurdur Y. Kristinsson Professor of Hematology, University of Iceland; Landspitali University Hospital · Landspítali, the National University Hospital of Iceland Leads iStopMM, which screened most of Iceland's adults for myeloma precursors to test whether early detection helps. | Multiple myeloma | none | myeloma, epidemiology | ||
Theodore R. Levin Associate Director, Cancer · Kaiser Permanente Division of Research Gastroenterologist who leads cancer research at Kaiser Permanente's Division of Research and is a leading figure in colorectal cancer screening. | Colorectal cancer | none | leadership, clinician-scientist, colorectal cancer | ||
Usha Menon Professor of Gynaecological Cancer, MRC Clinical Trials Unit at UCL · University College London Hospitals / UCL Cancer Institute Led UKCTOCS, the 200,000-woman trial that found ovarian cancer screening does not save lives despite detecting cancers earlier. | Ovarian cancer | none | ovarian, early-detection |